Global Autoimmune Disease Diagnostics Market 2024-2028

The autoimmune disease diagnostics market is forecasted to grow by USD 2,988.16 mn during 2023-2028, accelerating at a CAGR of 9.59% during the forecast period. The report on the autoimmune disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in laboratory automation platforms, discovery of novel biomarkers leading to improved autoimmune disease diagnosis, and increasing M and A activities among market vendors.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	8.85%
CAGR	9.59%
Incremental Value	$2988.16mn

Technavio's autoimmune disease diagnostics market is segmented as below:

By Type

Localized autoimmune disease diagnostics
Systemic autoimmune disease diagnostics

By Product

Assay kits
Analyzer

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the focus on companion diagnostic tests as one of the prime reasons driving the autoimmune disease diagnostics market growth during the next few years. Also, a shift from monoplex to multiplex testing and a growing preference for direct-to-consumer testing will lead to sizable demand in the market.

The report on the autoimmune disease diagnostics market covers the following areas:

Autoimmune disease diagnostics market sizing
Autoimmune disease diagnostics market forecast
Autoimmune disease diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune disease diagnostics market vendors that include Autoimmune Technologies LLC, Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, Exagen Inc., F. Hoffmann La Roche Ltd., Gold Standard Diagnostics Corp., Grifols SA, Hemagen Diagnostics Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Immco Diagnostics Inc., Laboratory Corp. of America Holdings, PerkinElmer Inc., Quest Diagnostics Inc., R Biopharm AG, Siemens AG, Svar Life Science AB, Thermo Fisher Scientific Inc., and Werfenlife SA. Also, the autoimmune disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR41431

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global autoimmune disease diagnostics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global autoimmune disease diagnostics market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Localized autoimmune disease diagnostics - Market size and forecast 2023-2028
Exhibit 34: Chart on Localized autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Localized autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Localized autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Localized autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
6.4 Systemic autoimmune disease diagnostics - Market size and forecast 2023-2028
Exhibit 38: Chart on Systemic autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Systemic autoimmune disease diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Systemic autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Systemic autoimmune disease diagnostics - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Assay kits - Market size and forecast 2023-2028
Exhibit 48: Chart on Assay kits - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Assay kits - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Assay kits - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Assay kits - Year-over-year growth 2023-2028 (%)
7.4 Analyzer - Market size and forecast 2023-2028
Exhibit 52: Chart on Analyzer - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Analyzer - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Analyzer - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Analyzer - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 56: Market opportunity by Product ($ million)
Exhibit 57: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Bio Rad Laboratories Inc.
Exhibit 107: Bio Rad Laboratories Inc. - Overview
Exhibit 108: Bio Rad Laboratories Inc. - Business segments
Exhibit 109: Bio Rad Laboratories Inc. - Key news
Exhibit 110: Bio Rad Laboratories Inc. - Key offerings
Exhibit 111: Bio Rad Laboratories Inc. - Segment focus
12.4 bioMerieux SA
Exhibit 112: bioMerieux SA - Overview
Exhibit 113: bioMerieux SA - Product / Service
Exhibit 114: bioMerieux SA - Key offerings
12.5 Danaher Corp.
Exhibit 115: Danaher Corp. - Overview
Exhibit 116: Danaher Corp. - Business segments
Exhibit 117: Danaher Corp. - Key news
Exhibit 118: Danaher Corp. - Key offerings
Exhibit 119: Danaher Corp. - Segment focus
12.6 DiaSorin SpA
Exhibit 120: DiaSorin SpA - Overview
Exhibit 121: DiaSorin SpA - Business segments
Exhibit 122: DiaSorin SpA - Key news
Exhibit 123: DiaSorin SpA - Key offerings
Exhibit 124: DiaSorin SpA - Segment focus
12.7 F. Hoffmann La Roche Ltd.
Exhibit 125: F. Hoffmann La Roche Ltd. - Overview
Exhibit 126: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 127: F. Hoffmann La Roche Ltd. - Key news
Exhibit 128: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 129: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Grifols SA
Exhibit 130: Grifols SA - Overview
Exhibit 131: Grifols SA - Business segments
Exhibit 132: Grifols SA - Key offerings
Exhibit 133: Grifols SA - Segment focus
12.9 Hemagen Diagnostics Inc.
Exhibit 134: Hemagen Diagnostics Inc. - Overview
Exhibit 135: Hemagen Diagnostics Inc. - Product / Service
Exhibit 136: Hemagen Diagnostics Inc. - Key offerings
12.10 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
Exhibit 137: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibit 138: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
Exhibit 139: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
12.11 Laboratory Corp. of America Holdings
Exhibit 140: Laboratory Corp. of America Holdings - Overview
Exhibit 141: Laboratory Corp. of America Holdings - Business segments
Exhibit 142: Laboratory Corp. of America Holdings - Key news
Exhibit 143: Laboratory Corp. of America Holdings - Key offerings
Exhibit 144: Laboratory Corp. of America Holdings - Segment focus
12.12 PerkinElmer Inc.
Exhibit 145: PerkinElmer Inc. - Overview
Exhibit 146: PerkinElmer Inc. - Business segments
Exhibit 147: PerkinElmer Inc. - Key news
Exhibit 148: PerkinElmer Inc. - Key offerings
Exhibit 149: PerkinElmer Inc. - Segment focus
12.13 Quest Diagnostics Inc.
Exhibit 150: Quest Diagnostics Inc. - Overview
Exhibit 151: Quest Diagnostics Inc. - Business segments
Exhibit 152: Quest Diagnostics Inc. - Key offerings
Exhibit 153: Quest Diagnostics Inc. - Segment focus
12.14 R Biopharm AG
Exhibit 154: R Biopharm AG - Overview
Exhibit 155: R Biopharm AG - Product / Service
Exhibit 156: R Biopharm AG - Key offerings
12.15 Siemens AG
Exhibit 157: Siemens AG - Overview
Exhibit 158: Siemens AG - Business segments
Exhibit 159: Siemens AG - Key news
Exhibit 160: Siemens AG - Key offerings
Exhibit 161: Siemens AG - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 162: Thermo Fisher Scientific Inc. - Overview
Exhibit 163: Thermo Fisher Scientific Inc. - Business segments
Exhibit 164: Thermo Fisher Scientific Inc. - Key news
Exhibit 165: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 166: Thermo Fisher Scientific Inc. - Segment focus
12.17 Werfenlife SA
Exhibit 167: Werfenlife SA - Overview
Exhibit 168: Werfenlife SA - Product / Service
Exhibit 169: Werfenlife SA - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations